![](/img/cover-not-exists.png)
Treatment of Crohn’s disease (CD): response to Remicade® (infliximab) in the ACCENT I trial through week 54
Paul Rutgeerts, Jean-Frederick Colombel, Stephen Schreiber, Lloyd Mayer, Gary Lichtenstein, Daniel Rachmilewicz, Doug Wolf, Helmut Malchow, Michael Safdi, Brian Feagan, Allan Olson, Stephen HanauerVolume:
96
Year:
2001
Language:
english
DOI:
10.1016/s0002-9270(01)03741-8
File:
PDF, 39 KB
english, 2001